GODAVARIB Godavari Biorefineries Q1 FY26 results (Apr–Jun 2025) and concall
Godavari Biorefineries Ltd reported a quarter of positive change in Q1 FY26, with revenue improving to INR533.2 crores and EBITDA turning positive at INR6.5 crores. The bio-based chemical segment showed strong growth, and interest costs reduced significantly. The company is advancing its ethanol expansion and drug discovery initiatives, despite inherent seasonality in some traditional segments.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 |
|---|---|---|---|---|
| Revenue | 321 | 447 | 580 | 533 |
| EBITDA | -33 | 36 | 112 | 6 |
| Net profit | -75 | 6 | 72 | -16 |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
